Skip to content

CCTAP: Cognitive Control Training for Treatment of AUD-PTSD

CCTAP: Cognitive Control Training for Treatment of AUD-PTSD

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03200028
Enrollment
9
Registered
2017-06-27
Start date
2018-04-01
Completion date
2019-02-28
Last updated
2019-10-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Alcohol Use Disorder, Post Traumatic Stress Disorder

Brief summary

The primary objective of this study is to evaluate the feasibility of the revised brain training program with individuals diagnosed with Alcohol Use Disorder (AUD) and Post-Traumatic Stress Disorder (PTSD).

Interventions

Thirty minutes of training on computerized exercises that targets executive function, memory and attention.

Sponsors

VA Palo Alto Health Care System
CollaboratorFED
Posit Science Corporation
Lead SponsorINDUSTRY

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* Participant is a Veteran and is enrolled in outpatient Substance Use Disorder treatment within Veteran Affairs Palo Alto Health Care System * Participant meets Diagnostic and Statistical Manual of Mental Disorders-5 criteria for current Alcohol Use Disorder and seeking treatment for Alcohol Use Disorder * Participant meets Meet Diagnostic and Statistical Manual of Mental Disorders-5 criteria for current PTSD * Participant must be willing to perform daily home-based computer exercises for 6 weeks * Participant must demonstrate mild cognitive deficit on neuropsychological tests at the screening visit * Participant must be a fluent English speaker from the age of 12 * Participant must have adequate sensorimotor capacity to perform the program, including visual capacity adequate to read from a iPad screen at a normal viewing distance, auditory capacity adequate to understand normal speech, and motor capacity adequate to control a touchpad

Exclusion criteria

* Participant with diagnosis of an illness or condition with known cognitive consequences (e.g., schizophrenia, bipolar disorder, cancer, multiple sclerosis, Traumatic Brain Injury, mental retardation or pervasive developmental disorder, epilepsy, Parkinson's Disease, delirium or dementia) * Participant with active suicidal ideations as measured by the Columbia-Suicide Severity Rating Scale (C-SSRS) * Participant with problems performing assessments or comprehending or following spoken instructions * Participant who has been treated within 5 years of the date of consent with a computer-based cognitive training program manufactured by Posit Science * Participant with current severe traumatic brain injury * Participant with any type of dementia * Participant with any type of mental retardation * Participant with limited ability to speak/read/write/understand English

Design outcomes

Primary

MeasureTime frameDescription
AcceptabilityAt 6 weeksAcceptability will be evaluated through Cognitive Training Acceptability Measure. This measure is comprised of 17 statements about their training experience and participants will be asked to rate each statement on a 7-point Likert scale from Strongly Disagree to Strongly Agree.
UsabilityAt 6 weeksUsability will be evaluated through the Computer System Usability Questionnaire and System Usability Scale. The Computer System Usability Questionnaire and System Usability Scale is comprised of a total of 29 statements and participants will be asked to rate the usability of the system on a 7-point Likert scale from Strongly Disagree to Strongly Agree.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026